Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ResMed
RMD
|
+$487M |
| 2 |
Mettler-Toledo International
MTD
|
+$445M |
| 3 |
Copart
CPRT
|
+$409M |
| 4 |
Johnson Controls International
JCI
|
+$364M |
| 5 |
Phillips 66
PSX
|
+$318M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$928M |
| 2 |
Microsoft
MSFT
|
+$910M |
| 3 |
Apple
AAPL
|
+$816M |
| 4 |
Walt Disney
DIS
|
+$687M |
| 5 |
Amazon
AMZN
|
+$484M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.48% |
| 2 | Healthcare | 12.31% |
| 3 | Financials | 11.99% |
| 4 | Consumer Discretionary | 9.58% |
| 5 | Industrials | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3826
Prelude Therapeutics
PRLD
$428M
| $190K | ﹤0.01% |
40,068
-10,532
| -21% | -$41K |
|
3827
DLH Holdings
DLHC
$68.7M
| $190K | ﹤0.01% |
14,310
-1,949
| -12% | -$30.1K |
|
3828
Cemex
CX
$16B
| $190K | ﹤0.01% |
21,074
+614
| +3% | +$4.92K |
|
3829
SKYX Platforms
SKYX
$148M
| $189K | ﹤0.01% |
144,527
-4,004
| -3% | -$5.77K |
|
3830
ESS Tech
GWH
$19.6M
| $188K | ﹤0.01% |
17,321
-1,935
| -10% | -$26.4K |
|
3831
374Water
SCWO
$44.6M
| $187K | ﹤0.01% |
14,864
-1,627
| -10% | -$21K |
|
|
EGRX
3832
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $185K | ﹤0.01% |
35,287
-6,548
| -16% | -$35.9K |
|
3833
Provident Financial
PROV
$113M
| $182K | ﹤0.01% |
13,601
-2,719
| -17% | -$38K |
|
|
CLPR
3834
Clipper Realty
CLPR
$53M
| $181K | ﹤0.01% |
37,572
-6,967
| -16% | -$34.5K |
|
3835
LanzaTech
LNZA
$68.9M
| $181K | ﹤0.01% |
585
-230
| -28% | -$85.4K |
|
3836
CION Investment
CION
$382M
| $180K | ﹤0.01% |
+16,354
| New | +$180K |
|
|
ORGN
3837
DELISTED
Origin Materials
ORGN
| $180K | ﹤0.01% |
11,739
-1,137
| -9% | -$19.7K |
|
3838
Vermilion Energy
VET
$1.72B
| $178K | ﹤0.01% |
14,317
-1
| -0% | -$11 |
|
3839
dLocal
DLO
$4.34B
| $178K | ﹤0.01% |
12,097
-1,026
| -8% | -$17.2K |
|
|
CARM
3840
DELISTED
Carisma Therapeutics
CARM
| $176K | ﹤0.01% |
77,712
-5,817
| -7% | -$14K |
|
3841
Acrivon Therapeutics
ACRV
$79.2M
| $175K | ﹤0.01% |
24,413
-382
| -2% | -$1.77K |
|
3842
Cue Biopharma
CUE
$131M
| $174K | ﹤0.01% |
3,074
-571
| -16% | -$40.3K |
|
|
ENLC
3843
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
| $173K | ﹤0.01% |
12,710
+1,922
| +18% | +$23.8K |
|
3844
Orchestra BioMed
OBIO
$267M
| $173K | ﹤0.01% |
32,776
-14,454
| -31% | -$97.9K |
|
3845
Fossil Group
FOSL
$330M
| $172K | ﹤0.01% |
168,263
-4,922
| -3% | -$5.49K |
|
3846
Hyperfine
HYPR
$94.7M
| $171K | ﹤0.01% |
171,495
-10,743
| -6% | -$11.5K |
|
3847
5E Advanced Materials
FEAM
$67.3M
| $169K | ﹤0.01% |
5,467
+123
| +2% | +$3.86K |
|
3848
LG Display
LPL
$3.37B
| $168K | ﹤0.01% |
41,008
-778
| -2% | -$3.48K |
|
3849
Village Farms International
VFF
$302M
| $168K | ﹤0.01% |
135,466
| – | – |
|
3850
Rallybio
RLYB
$90.1M
| $167K | ﹤0.01% |
11,290
+5
| +0% | +$70 |
|
Similar funds
Bank of New York Mellon's Q1 2024 Portfolio in Review
As of Q1 2024, Bank of New York Mellon held 4,422 positions worth $521B, up 5.6% from $493B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Bank of New York Mellon withdrew a net $17.6B in Q1 2024, closing 270 positions and reducing 3,087 holdings. Its most notable exit was Splunk Inc, an estimated $143M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Bank of New York Mellon opened a new position in Vanguard International Dividend Appreciation ETF worth $127M.
- Bank of New York Mellon's largest Q1 2024 buy was Vanguard International Dividend Appreciation ETF: 1,562,136 shares worth $127M.
- Bank of New York Mellon added most to ResMed in Q1 2024, an estimated $487M increase.
- Bank of New York Mellon's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $928M.
- Bank of New York Mellon fully exited Splunk Inc in Q1 2024, selling an estimated $143M.
- Bank of New York Mellon's ten largest holdings make up 22% of its $521B portfolio in Q1 2024.
- Bank of New York Mellon opened 113 new positions and closed 270 in Q1 2024.
- Bank of New York Mellon's portfolio value rose 5.6% quarter-over-quarter to $521B.
Based on Bank of New York Mellon's 13F filing for Q1 2024, filed 25 Apr 2024.